CH645892A5 - Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel. - Google Patents
Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel. Download PDFInfo
- Publication number
- CH645892A5 CH645892A5 CH694080A CH694080A CH645892A5 CH 645892 A5 CH645892 A5 CH 645892A5 CH 694080 A CH694080 A CH 694080A CH 694080 A CH694080 A CH 694080A CH 645892 A5 CH645892 A5 CH 645892A5
- Authority
- CH
- Switzerland
- Prior art keywords
- piperidyl
- propoxy
- dihydrocarbostyril
- carbostyril
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 364
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title claims description 78
- 238000000034 method Methods 0.000 title claims description 40
- 239000013543 active substance Substances 0.000 title 1
- -1 hydroxycarbostyril compound Chemical class 0.000 claims description 119
- 150000003839 salts Chemical class 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 27
- 125000005843 halogen group Chemical group 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000000739 antihistaminic agent Substances 0.000 claims description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 17
- 150000007514 bases Chemical class 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- 229910052727 yttrium Inorganic materials 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- 125000000304 alkynyl group Chemical group 0.000 claims description 9
- 125000003342 alkenyl group Chemical group 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- CPXJWPACAUOGMV-UHFFFAOYSA-N 7-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2CCC(=O)NC2=CC=1OCC(O)CN(CC1)CCC1C1=CC=CC=C1 CPXJWPACAUOGMV-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 150000003053 piperidines Chemical class 0.000 claims description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- GUXWIKFZXZAIRK-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2NC(=O)CCC2=CC=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 GUXWIKFZXZAIRK-UHFFFAOYSA-N 0.000 claims description 2
- DCEHMYOYSWLMFZ-UHFFFAOYSA-N 7-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2NC(=O)CCC2=CC=C1OCCCN(CC1)CCC1C1=CC=CC=C1 DCEHMYOYSWLMFZ-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 172
- 239000013078 crystal Substances 0.000 description 141
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 138
- 238000006243 chemical reaction Methods 0.000 description 81
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 75
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 70
- 235000019441 ethanol Nutrition 0.000 description 65
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 60
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 52
- 239000000203 mixture Substances 0.000 description 51
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 30
- 239000011541 reaction mixture Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 22
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 22
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
- 230000002829 reductive effect Effects 0.000 description 22
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 21
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 20
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 18
- 238000001914 filtration Methods 0.000 description 18
- 235000002639 sodium chloride Nutrition 0.000 description 16
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 13
- 239000007858 starting material Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 230000001387 anti-histamine Effects 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- 229960001340 histamine Drugs 0.000 description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 239000008101 lactose Substances 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 235000011121 sodium hydroxide Nutrition 0.000 description 8
- TZOYXRMEFDYWDQ-UHFFFAOYSA-N 3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)CCC2=C1 TZOYXRMEFDYWDQ-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- 229940125715 antihistaminic agent Drugs 0.000 description 7
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 7
- 235000006408 oxalic acid Nutrition 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- ABGXADJDTPFFSZ-UHFFFAOYSA-N 4-benzylpiperidine Chemical compound C=1C=CC=CC=1CC1CCNCC1 ABGXADJDTPFFSZ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 235000001727 glucose Nutrition 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 230000002140 halogenating effect Effects 0.000 description 6
- 239000012442 inert solvent Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- FPDRUJPKJHLDBO-UHFFFAOYSA-N 5-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=CC=2NC(=O)CCC=2C=1OCC(O)CN(CC1)CCC1C1=CC=CC=C1 FPDRUJPKJHLDBO-UHFFFAOYSA-N 0.000 description 5
- OOFRFJYTNGYDOT-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-8-bromo-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C(Br)C=2NC(=O)CCC=2C=1OCC(O)CN(CC1)CCC1CC1=CC=CC=C1 OOFRFJYTNGYDOT-UHFFFAOYSA-N 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 5
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 210000003405 ileum Anatomy 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 5
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Inorganic materials [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 4
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 4
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 4
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 4
- ZSHZOONYRBYGNV-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCCCN(CC1)CCC1CC1=CC=CC=C1 ZSHZOONYRBYGNV-UHFFFAOYSA-N 0.000 description 4
- MAJOEGDVHADATN-UHFFFAOYSA-N 6-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCC(O)CN(CC1)CCC1C1=CC=CC=C1 MAJOEGDVHADATN-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003874 central nervous system depressant Substances 0.000 description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 3
- ZUGRYLJRHKHZLR-UHFFFAOYSA-N 1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=CC=C2NC(=O)C=CC2=C1 ZUGRYLJRHKHZLR-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 3
- ZIUFOCSWSPYALC-UHFFFAOYSA-N 4-phenyl-7-[3-(4-phenylpiperidin-1-yl)propoxy]-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C12=CC=C(OCCCN3CCC(CC3)C=3C=CC=CC=3)C=C2NC(=O)C=C1C1=CC=CC=C1 ZIUFOCSWSPYALC-UHFFFAOYSA-N 0.000 description 3
- BZEYZBGSCGYVKC-UHFFFAOYSA-N 5-[3-(4-acetyl-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 BZEYZBGSCGYVKC-UHFFFAOYSA-N 0.000 description 3
- BFEQDZNCCKMXOP-UHFFFAOYSA-N 5-[3-(4-hydroxy-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1(O)C1=CC=CC=C1 BFEQDZNCCKMXOP-UHFFFAOYSA-N 0.000 description 3
- UTTJAIFHRUAFED-UHFFFAOYSA-N 5-hydroxy-3,4-dihydro-2(1h)-quinolinone Chemical compound N1C(=O)CCC2=C1C=CC=C2O UTTJAIFHRUAFED-UHFFFAOYSA-N 0.000 description 3
- WEFCOUPECCVVSW-UHFFFAOYSA-N 6-[3-(4-benzylpiperidin-1-yl)propoxy]-4-methyl-1h-quinolin-2-one Chemical compound C1=C2C(C)=CC(=O)NC2=CC=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 WEFCOUPECCVVSW-UHFFFAOYSA-N 0.000 description 3
- KZNFNFJBVRWYRD-UHFFFAOYSA-N 7-[3-(4-acetyl-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 KZNFNFJBVRWYRD-UHFFFAOYSA-N 0.000 description 3
- ZVIURFHDXIMZNQ-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)propoxy]-4-methyl-1h-quinolin-2-one Chemical compound C=1C=C2C(C)=CC(=O)NC2=CC=1OCCCN(CC1)CCC1CC1=CC=CC=C1 ZVIURFHDXIMZNQ-UHFFFAOYSA-N 0.000 description 3
- KMRFMMHCOOMPMW-UHFFFAOYSA-N 7-[3-(4-hydroxy-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1(O)C1=CC=CC=C1 KMRFMMHCOOMPMW-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 2
- MGGPPWUZJGYEMN-UHFFFAOYSA-N (8-bromo-2-oxo-3,4-dihydro-1h-quinolin-5-yl) acetate Chemical compound N1C(=O)CCC2=C1C(Br)=CC=C2OC(=O)C MGGPPWUZJGYEMN-UHFFFAOYSA-N 0.000 description 2
- RKHWHRHOEKYEJW-UHFFFAOYSA-N 1-(4-phenylpiperidin-4-yl)ethanone Chemical compound C=1C=CC=CC=1C1(C(=O)C)CCNCC1 RKHWHRHOEKYEJW-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 2
- KQKFQBTWXOGINC-UHFFFAOYSA-N 4-phenylpiperidin-4-ol Chemical compound C=1C=CC=CC=1C1(O)CCNCC1 KQKFQBTWXOGINC-UHFFFAOYSA-N 0.000 description 2
- JHWVAWUKMRXHCM-UHFFFAOYSA-N 5-(3-chloropropoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCCCCl JHWVAWUKMRXHCM-UHFFFAOYSA-N 0.000 description 2
- APZRSBHFLLLLKA-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;hydrochloride Chemical compound Cl.N1C(=O)CCC2=C1C=CC=C2OCCCN(CC1)CCC1CC1=CC=CC=C1 APZRSBHFLLLLKA-UHFFFAOYSA-N 0.000 description 2
- ICJIWDXQEIAORY-UHFFFAOYSA-N 6,8-dichloro-5-[2-methyl-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound ClC=1C=C(Cl)C=2NC(=O)CCC=2C=1OCC(C)CN(CC1)CCC1C1=CC=CC=C1 ICJIWDXQEIAORY-UHFFFAOYSA-N 0.000 description 2
- OGHVHWURQPBPBZ-UHFFFAOYSA-N 6,8-dichloro-5-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C(Cl)=CC(Cl)=C2O OGHVHWURQPBPBZ-UHFFFAOYSA-N 0.000 description 2
- XWKDOHOYVPPFBP-UHFFFAOYSA-N 6-[2-(4-acetyl-4-phenylpiperidin-1-yl)ethoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCOC=2C=C3CCC(=O)NC3=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 XWKDOHOYVPPFBP-UHFFFAOYSA-N 0.000 description 2
- JUNLFHGDBPFMOO-UHFFFAOYSA-N 6-[3-(4-acetyl-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3CCC(=O)NC3=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 JUNLFHGDBPFMOO-UHFFFAOYSA-N 0.000 description 2
- XNLAGCRQVZPJBO-UHFFFAOYSA-N 6-[3-(4-benzylpiperidin-1-yl)propoxy]-4-methyl-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=C2C(C)=CC(=O)NC2=CC=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 XNLAGCRQVZPJBO-UHFFFAOYSA-N 0.000 description 2
- KPUQMPJEVWQIBR-UHFFFAOYSA-N 6-chloro-7-methoxy-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=C(OC)C(Cl)=C2 KPUQMPJEVWQIBR-UHFFFAOYSA-N 0.000 description 2
- UGZYIGMQFDGEDN-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;oxalic acid Chemical compound OC(=O)C(O)=O.C1=C2NC(=O)CCC2=CC=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 UGZYIGMQFDGEDN-UHFFFAOYSA-N 0.000 description 2
- UCILZXJBXSPMEL-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)propoxy]-4-methyl-1H-quinolin-2-one dihydrate hydrochloride Chemical compound O.O.Cl.C=1C=C2C(C)=CC(=O)NC2=CC=1OCCCN(CC1)CCC1CC1=CC=CC=C1 UCILZXJBXSPMEL-UHFFFAOYSA-N 0.000 description 2
- YQWAUTXZXHJYJX-UHFFFAOYSA-N 7-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=C2NC(=O)CCC2=CC=C1OCCCN(CC1)CCC1C1=CC=CC=C1 YQWAUTXZXHJYJX-UHFFFAOYSA-N 0.000 description 2
- KFSVFFPJJXNTRL-UHFFFAOYSA-N 7-[5-(4-benzylpiperidin-1-yl)pentoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2NC(=O)CCC2=CC=C1OCCCCCN(CC1)CCC1CC1=CC=CC=C1 KFSVFFPJJXNTRL-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005658 halogenation reaction Methods 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- WWNUOEHSLVYAIK-UHFFFAOYSA-N oxalic acid;7-[3-(4-phenylpiperidin-1-yl)propoxy]-1-(3-phenylpropyl)-3,4-dihydroquinolin-2-one Chemical compound OC(=O)C(O)=O.C1=C2N(CCCC=3C=CC=CC=3)C(=O)CCC2=CC=C1OCCCN(CC1)CCC1C1=CC=CC=C1 WWNUOEHSLVYAIK-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- HHAVHBDPWSUKHZ-UHFFFAOYSA-N propan-2-ol;propan-2-one Chemical compound CC(C)O.CC(C)=O HHAVHBDPWSUKHZ-UHFFFAOYSA-N 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- XWUYPTBLYBFMST-UHFFFAOYSA-N (2-oxo-3,4-dihydro-1h-quinolin-5-yl) acetate Chemical compound N1C(=O)CCC2=C1C=CC=C2OC(=O)C XWUYPTBLYBFMST-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CLHCZSMFTFHAJK-UHFFFAOYSA-N 1,4-dimethyl-7-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydroquinolin-2-one Chemical compound C=1C=C2C(C)CC(=O)N(C)C2=CC=1OCCCN(CC1)CCC1C1=CC=CC=C1 CLHCZSMFTFHAJK-UHFFFAOYSA-N 0.000 description 1
- MEUVQYDLGMHBHQ-UHFFFAOYSA-N 1-(3-chloropropyl)-4-phenylpiperidin-4-ol;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C1(O)CCN(CCCCl)CC1 MEUVQYDLGMHBHQ-UHFFFAOYSA-N 0.000 description 1
- QCZZSANNLWPGEA-UHFFFAOYSA-N 1-(4-phenylphenyl)ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC=CC=C1 QCZZSANNLWPGEA-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- YELBPDGGWQHBJC-UHFFFAOYSA-N 1-[1-(oxiran-2-ylmethyl)-4-phenylpiperidin-4-yl]ethanone Chemical compound C1CC(C(=O)C)(C=2C=CC=CC=2)CCN1CC1CO1 YELBPDGGWQHBJC-UHFFFAOYSA-N 0.000 description 1
- BLIQUJLAJXRXSG-UHFFFAOYSA-N 1-benzyl-3-(trifluoromethyl)pyrrolidin-1-ium-3-carboxylate Chemical compound C1C(C(=O)O)(C(F)(F)F)CCN1CC1=CC=CC=C1 BLIQUJLAJXRXSG-UHFFFAOYSA-N 0.000 description 1
- ZNNBZKFZOVHYPX-UHFFFAOYSA-N 1-benzyl-7-[2-methyl-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydroquinolin-2-one Chemical compound C1CC(C=2C=CC=CC=2)CCN1CC(C)COC(C=C12)=CC=C1CCC(=O)N2CC1=CC=CC=C1 ZNNBZKFZOVHYPX-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- 125000006016 2-bromoethoxy group Chemical group 0.000 description 1
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000004813 2-ethylethylene group Chemical group [H]C([H])([H])C([H])([H])C([H])([*:2])C([H])([H])[*:1] 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- AZXTVJCVWZNIQC-UHFFFAOYSA-N 3,4-dihydro-1h-quinolin-2-one;oxalic acid Chemical compound OC(=O)C(O)=O.C1=CC=C2NC(=O)CCC2=C1 AZXTVJCVWZNIQC-UHFFFAOYSA-N 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- FVXYRXMYPXVHNY-UHFFFAOYSA-N 3-propoxy-3,4-dihydro-1H-quinolin-2-one Chemical compound C(CC)OC1C(NC2=CC=CC=C2C1)=O FVXYRXMYPXVHNY-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- KZETVBNJADWALK-UHFFFAOYSA-N 4-benzyl-1-(oxiran-2-ylmethyl)piperidine Chemical compound C1CC(CC=2C=CC=CC=2)CCN1CC1CO1 KZETVBNJADWALK-UHFFFAOYSA-N 0.000 description 1
- HDHQZCHIXUUSMK-UHFFFAOYSA-N 4-hydroxy-2-quinolone Chemical compound C1=CC=C2C(O)=CC(=O)NC2=C1 HDHQZCHIXUUSMK-UHFFFAOYSA-N 0.000 description 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- DIEHBVZAICNOIL-UHFFFAOYSA-N 4-methyl-5-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12C(C)CC(=O)NC2=CC=CC=1OCCCN(CC1)CCC1C1=CC=CC=C1 DIEHBVZAICNOIL-UHFFFAOYSA-N 0.000 description 1
- PBWNNMXPKXZYAH-UHFFFAOYSA-N 4-methyl-6-[3-[4-(4-methylphenyl)piperidin-1-yl]propoxy]-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=CC(C)=CC=C1C1CCN(CCCOC=2C=C3C(C)=CC(=O)NC3=CC=2)CC1 PBWNNMXPKXZYAH-UHFFFAOYSA-N 0.000 description 1
- VAFMNKKAZVXGSZ-UHFFFAOYSA-N 4-methyl-7-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2C(C)CC(=O)NC2=CC=1OCCCN(CC1)CCC1C1=CC=CC=C1 VAFMNKKAZVXGSZ-UHFFFAOYSA-N 0.000 description 1
- ICJLPYOHFZGFNQ-UHFFFAOYSA-N 4-phenyl-7-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C12=CC=C(OCCCN3CCC(CC3)C=3C=CC=CC=3)C=C2NC(=O)CC1C1=CC=CC=C1 ICJLPYOHFZGFNQ-UHFFFAOYSA-N 0.000 description 1
- UTBULQCHEUWJNV-UHFFFAOYSA-N 4-phenylpiperidine Chemical compound C1CNCCC1C1=CC=CC=C1 UTBULQCHEUWJNV-UHFFFAOYSA-N 0.000 description 1
- VQTWQOBNPISQPG-UHFFFAOYSA-N 5-(oxiran-2-ylmethoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC1CO1 VQTWQOBNPISQPG-UHFFFAOYSA-N 0.000 description 1
- CEBWQKRBJHNGTK-UHFFFAOYSA-N 5-[(4-benzylpiperidin-1-yl)methoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCN(CC1)CCC1CC1=CC=CC=C1 CEBWQKRBJHNGTK-UHFFFAOYSA-N 0.000 description 1
- OIVRQFIELHWDHQ-UHFFFAOYSA-N 5-[2-(4-benzylpiperidin-1-yl)ethoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCCN(CC1)CCC1CC1=CC=CC=C1 OIVRQFIELHWDHQ-UHFFFAOYSA-N 0.000 description 1
- NKRGBTDYGJBQJI-UHFFFAOYSA-N 5-[2-(4-hydroxy-4-phenylpiperidin-1-yl)ethoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1(O)C1=CC=CC=C1 NKRGBTDYGJBQJI-UHFFFAOYSA-N 0.000 description 1
- GPVOEMKUZBBNHC-UHFFFAOYSA-N 5-[2-hydroxy-3-(3,4,5-trimethoxyphenyl)propoxy]-3,4-dihydro-1h-quinolin-2-one;oxalic acid Chemical compound OC(=O)C(O)=O.COC1=C(OC)C(OC)=CC(CC(O)COC=2C=3CCC(=O)NC=3C=CC=2)=C1 GPVOEMKUZBBNHC-UHFFFAOYSA-N 0.000 description 1
- CESFCBJCZGHMOT-UHFFFAOYSA-N 5-[2-hydroxy-3-(4-hydroxy-4-phenylpiperidin-1-yl)propoxy]-4-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12C(C)CC(=O)NC2=CC=CC=1OCC(O)CN(CC1)CCC1(O)C1=CC=CC=C1 CESFCBJCZGHMOT-UHFFFAOYSA-N 0.000 description 1
- ULQHEOIVTFNSRO-UHFFFAOYSA-N 5-[2-hydroxy-3-[4-(4-methoxyphenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].C1=CC(OC)=CC=C1C1CC[N+](C)(CC(O)COC=2C=3C=CC(=O)NC=3C=CC=2)CC1 ULQHEOIVTFNSRO-UHFFFAOYSA-N 0.000 description 1
- AOBDONJGLWDHGL-UHFFFAOYSA-N 5-[3-(4-acetyl-4-phenylpiperidin-1-yl)-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CC(O)COC=2C=3CCC(=O)NC=3C=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 AOBDONJGLWDHGL-UHFFFAOYSA-N 0.000 description 1
- TVVHVMXRWNRFDS-UHFFFAOYSA-N 5-[3-(4-acetyl-4-phenylpiperidin-1-yl)-2-hydroxypropoxy]-4-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12C(C)CC(=O)NC2=CC=CC=1OCC(O)CN(CC1)CCC1(C(C)=O)C1=CC=CC=C1 TVVHVMXRWNRFDS-UHFFFAOYSA-N 0.000 description 1
- YBEXYGVBZXJONN-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=CC=2NC(=O)CCC=2C=1OCC(O)CN(CC1)CCC1CC1=CC=CC=C1 YBEXYGVBZXJONN-UHFFFAOYSA-N 0.000 description 1
- XOTWCWWLQGYADY-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-4-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12C(C)CC(=O)NC2=CC=CC=1OCC(O)CN(CC1)CCC1CC1=CC=CC=C1 XOTWCWWLQGYADY-UHFFFAOYSA-N 0.000 description 1
- DWAUKFSXSLUIFO-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-4-phenyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(CC=2C=CC=CC=2)CCN1CC(O)COC(C1=2)=CC=CC=2NC(=O)CC1C1=CC=CC=C1 DWAUKFSXSLUIFO-UHFFFAOYSA-N 0.000 description 1
- CSGOTAHRMWMKQT-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-6,8-dibromo-3,4-dihydro-1h-quinolin-2-one Chemical compound BrC=1C=C(Br)C=2NC(=O)CCC=2C=1OCC(O)CN(CC1)CCC1CC1=CC=CC=C1 CSGOTAHRMWMKQT-UHFFFAOYSA-N 0.000 description 1
- JFEMPAHRCCLPQP-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)-2-methylpropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=CC=2NC(=O)CCC=2C=1OCC(C)CN(CC1)CCC1CC1=CC=CC=C1 JFEMPAHRCCLPQP-UHFFFAOYSA-N 0.000 description 1
- KDRYTAXPHBTCKU-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)propoxy]-4-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12C(C)CC(=O)NC2=CC=CC=1OCCCN(CC1)CCC1CC1=CC=CC=C1 KDRYTAXPHBTCKU-UHFFFAOYSA-N 0.000 description 1
- WYGBGXYPHSLLCG-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)propoxy]-6,8-dichloro-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=2CCC(=O)NC=2C(Cl)=CC(Cl)=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 WYGBGXYPHSLLCG-UHFFFAOYSA-N 0.000 description 1
- MLZFXXPTNHKUQW-UHFFFAOYSA-N 5-[3-(4-benzylpiperidin-1-yl)propoxy]-8-bromo-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=2CCC(=O)NC=2C(Br)=CC=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 MLZFXXPTNHKUQW-UHFFFAOYSA-N 0.000 description 1
- VZLBLDZJVPPEBK-UHFFFAOYSA-N 5-[3-(4-hexanoyl-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1(C(=O)CCCCC)C1=CC=CC=C1 VZLBLDZJVPPEBK-UHFFFAOYSA-N 0.000 description 1
- MDACWXBRDYAGLF-UHFFFAOYSA-N 5-[3-(4-hydroxy-4-phenylpiperidin-1-yl)propoxy]-4-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12C(C)CC(=O)NC2=CC=CC=1OCCCN(CC1)CCC1(O)C1=CC=CC=C1 MDACWXBRDYAGLF-UHFFFAOYSA-N 0.000 description 1
- GCFAAFHLMYZOMK-UHFFFAOYSA-N 5-[3-(4-phenyl-4-propanoylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1(C(=O)CC)C1=CC=CC=C1 GCFAAFHLMYZOMK-UHFFFAOYSA-N 0.000 description 1
- BULYEIAMVDJECR-UHFFFAOYSA-N 5-[3-(4-phenylpiperidin-1-yl)propoxy]-1h-quinolin-2-one;hydrochloride Chemical compound Cl.C1=CC=C2NC(=O)C=CC2=C1OCCCN(CC1)CCC1C1=CC=CC=C1 BULYEIAMVDJECR-UHFFFAOYSA-N 0.000 description 1
- LRGDBKJBYCYCLJ-UHFFFAOYSA-N 5-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCCCN(CC1)CCC1C1=CC=CC=C1 LRGDBKJBYCYCLJ-UHFFFAOYSA-N 0.000 description 1
- LKTJKEHEESFBGK-UHFFFAOYSA-N 5-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;hydrochloride Chemical compound Cl.N1C(=O)CCC2=C1C=CC=C2OCCCN(CC1)CCC1C1=CC=CC=C1 LKTJKEHEESFBGK-UHFFFAOYSA-N 0.000 description 1
- PWFQBKHOYBGHFZ-UHFFFAOYSA-N 5-[4-(4-benzylpiperidin-1-yl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCCCCN(CC1)CCC1CC1=CC=CC=C1 PWFQBKHOYBGHFZ-UHFFFAOYSA-N 0.000 description 1
- ZAKFLEYTVGEFDA-UHFFFAOYSA-N 5-[4-(4-hydroxy-4-phenylpiperidin-1-yl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1(O)C1=CC=CC=C1 ZAKFLEYTVGEFDA-UHFFFAOYSA-N 0.000 description 1
- PXZKGLMRQOVXQW-UHFFFAOYSA-N 6,8-dichloro-5-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound ClC=1C=C(Cl)C=2NC(=O)CCC=2C=1OCC(O)CN(CC1)CCC1C1=CC=CC=C1 PXZKGLMRQOVXQW-UHFFFAOYSA-N 0.000 description 1
- YVPNRKUVAJQGPD-UHFFFAOYSA-N 6,8-dichloro-5-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=2CCC(=O)NC=2C(Cl)=CC(Cl)=C1OCCCN(CC1)CCC1C1=CC=CC=C1 YVPNRKUVAJQGPD-UHFFFAOYSA-N 0.000 description 1
- BPSCGYGLXVBSGI-UHFFFAOYSA-N 6-(3-chloropropoxy)-4-methyl-1h-quinolin-2-one Chemical compound C1=C(OCCCCl)C=C2C(C)=CC(=O)NC2=C1 BPSCGYGLXVBSGI-UHFFFAOYSA-N 0.000 description 1
- JCUCRSQXCFRHMC-UHFFFAOYSA-N 6-[2-(4-acetyl-4-phenylpiperidin-1-yl)ethoxy]-1h-quinolin-2-one Chemical compound C1CN(CCOC=2C=C3C=CC(=O)NC3=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 JCUCRSQXCFRHMC-UHFFFAOYSA-N 0.000 description 1
- RGMLTQCSRFFRON-UHFFFAOYSA-N 6-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-1-(4-phenylbutyl)-3,4-dihydroquinolin-2-one Chemical compound C1CC(C=2C=CC=CC=2)CCN1CC(O)COC(C=C1CCC2=O)=CC=C1N2CCCCC1=CC=CC=C1 RGMLTQCSRFFRON-UHFFFAOYSA-N 0.000 description 1
- BOMCVAAFVPJKIR-UHFFFAOYSA-N 6-[3-(4-acetyl-4-phenylpiperidin-1-yl)propoxy]-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3C=CC(=O)NC3=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 BOMCVAAFVPJKIR-UHFFFAOYSA-N 0.000 description 1
- YPJZMMZNQVQOKI-UHFFFAOYSA-N 6-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCC(O)CN(CC1)CCC1CC1=CC=CC=C1 YPJZMMZNQVQOKI-UHFFFAOYSA-N 0.000 description 1
- MCEPZEWBMQPXCE-UHFFFAOYSA-N 6-[3-(4-benzylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCN(CC1)CCC1CC1=CC=CC=C1 MCEPZEWBMQPXCE-UHFFFAOYSA-N 0.000 description 1
- NUYBDDICQIPMHV-UHFFFAOYSA-N 6-[3-(4-benzylpiperidin-1-yl)propoxy]-4-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2C(C)CC(=O)NC2=CC=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 NUYBDDICQIPMHV-UHFFFAOYSA-N 0.000 description 1
- DFZUGEMQTPBVCI-UHFFFAOYSA-N 6-[3-(4-hexanoyl-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3CCC(=O)NC3=CC=2)CCC1(C(=O)CCCCC)C1=CC=CC=C1 DFZUGEMQTPBVCI-UHFFFAOYSA-N 0.000 description 1
- NXHVTENNLTZKCH-UHFFFAOYSA-N 6-[3-(4-hydroxy-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3CCC(=O)NC3=CC=2)CCC1(O)C1=CC=CC=C1 NXHVTENNLTZKCH-UHFFFAOYSA-N 0.000 description 1
- AESOHGXFFNWJOS-UHFFFAOYSA-N 6-[3-(4-phenyl-4-propanoylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3CCC(=O)NC3=CC=2)CCC1(C(=O)CC)C1=CC=CC=C1 AESOHGXFFNWJOS-UHFFFAOYSA-N 0.000 description 1
- VEJPVHSBQMALBJ-UHFFFAOYSA-N 6-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCN(CC1)CCC1C1=CC=CC=C1 VEJPVHSBQMALBJ-UHFFFAOYSA-N 0.000 description 1
- HKLLMFOCCCMRQF-UHFFFAOYSA-N 6-chloro-5-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound ClC=1C=CC=2NC(=O)CCC=2C=1OCC(O)CN(CC1)CCC1C1=CC=CC=C1 HKLLMFOCCCMRQF-UHFFFAOYSA-N 0.000 description 1
- WIFRWNDBJXMOBF-UHFFFAOYSA-N 6-chloro-7-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=C(O)C(Cl)=C2 WIFRWNDBJXMOBF-UHFFFAOYSA-N 0.000 description 1
- RRZFNTBZWMYPMS-UHFFFAOYSA-N 6-fluoro-7-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=2NC(=O)CCC=2C=C(F)C=1OCC(O)CN(CC1)CCC1C1=CC=CC=C1 RRZFNTBZWMYPMS-UHFFFAOYSA-N 0.000 description 1
- NQCVIXJSFZMILF-UHFFFAOYSA-N 7-(3-chloropropoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=CC(OCCCCl)=CC=C21 NQCVIXJSFZMILF-UHFFFAOYSA-N 0.000 description 1
- MVTCRMKQTHRHRX-UHFFFAOYSA-N 7-(5-bromopentoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=CC(OCCCCCBr)=CC=C21 MVTCRMKQTHRHRX-UHFFFAOYSA-N 0.000 description 1
- IZSHHEZAWRCRGA-UHFFFAOYSA-N 7-[2-(4-benzylpiperidin-1-yl)ethoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2NC(=O)CCC2=CC=C1OCCN(CC1)CCC1CC1=CC=CC=C1 IZSHHEZAWRCRGA-UHFFFAOYSA-N 0.000 description 1
- ZNYLUDSCCVYUSE-UHFFFAOYSA-N 7-[2-(4-hydroxy-4-phenylpiperidin-1-yl)ethoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCOC=2C=C3NC(=O)CCC3=CC=2)CCC1(O)C1=CC=CC=C1 ZNYLUDSCCVYUSE-UHFFFAOYSA-N 0.000 description 1
- GNDJZSGUIOHNGZ-UHFFFAOYSA-N 7-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-4-phenyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(C=2C=CC=CC=2)CCN1CC(O)COC(C=C1NC(=O)C2)=CC=C1C2C1=CC=CC=C1 GNDJZSGUIOHNGZ-UHFFFAOYSA-N 0.000 description 1
- ZYWSWNOBWKJCOW-UHFFFAOYSA-N 7-[2-hydroxy-3-[1-methyl-4-(2-methylphenyl)piperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].CC1=CC=CC=C1C1CC[N+](C)(CC(O)COC=2C=C3NC(=O)C=CC3=CC=2)CC1 ZYWSWNOBWKJCOW-UHFFFAOYSA-N 0.000 description 1
- YFXPOWMSGQWJAN-UHFFFAOYSA-N 7-[2-hydroxy-4-(4-hydroxy-4-phenylpiperidin-1-yl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2CCC(=O)NC2=CC=1OCC(O)CCN(CC1)CCC1(O)C1=CC=CC=C1 YFXPOWMSGQWJAN-UHFFFAOYSA-N 0.000 description 1
- QDXHSQRGQKZRHJ-UHFFFAOYSA-N 7-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-1H-quinolin-2-one iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=C3NC(=O)C=CC3=CC=2)CCC1C1=CC=CC=C1 QDXHSQRGQKZRHJ-UHFFFAOYSA-N 0.000 description 1
- AKWQBZNAXPUQJR-UHFFFAOYSA-N 7-[3-(4-acetyl-4-phenylpiperidin-1-yl)-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CC(O)COC=2C=C3NC(=O)CCC3=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 AKWQBZNAXPUQJR-UHFFFAOYSA-N 0.000 description 1
- WCNHIBWDPIVCBA-UHFFFAOYSA-N 7-[3-(4-acetyl-4-phenylpiperidin-1-yl)-2-hydroxypropoxy]-4-phenyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(C(=O)C)(C=2C=CC=CC=2)CCN1CC(O)COC(C=C1NC(=O)C2)=CC=C1C2C1=CC=CC=C1 WCNHIBWDPIVCBA-UHFFFAOYSA-N 0.000 description 1
- LPIWBHMXBANGPS-UHFFFAOYSA-N 7-[3-(4-acetyl-4-phenylpiperidin-1-yl)propoxy]-4-phenyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(C(=O)C)(C=2C=CC=CC=2)CCN1CCCOC(C=C1NC(=O)C2)=CC=C1C2C1=CC=CC=C1 LPIWBHMXBANGPS-UHFFFAOYSA-N 0.000 description 1
- LUPBFIQJGPRFOE-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)-2,2-dimethylpropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2CCC(=O)NC2=CC=1OCC(C)(C)CN(CC1)CCC1CC1=CC=CC=C1 LUPBFIQJGPRFOE-UHFFFAOYSA-N 0.000 description 1
- QBYWODTYXPSOJA-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2CCC(=O)NC2=CC=1OCC(O)CN(CC1)CCC1CC1=CC=CC=C1 QBYWODTYXPSOJA-UHFFFAOYSA-N 0.000 description 1
- IZYKGGXUPSLAEZ-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)-2-methylpropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2CCC(=O)NC2=CC=1OCC(C)CN(CC1)CCC1CC1=CC=CC=C1 IZYKGGXUPSLAEZ-UHFFFAOYSA-N 0.000 description 1
- WGNUAIUETGJVLG-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)propoxy]-4-methyl-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2C(C)CC(=O)NC2=CC=1OCCCN(CC1)CCC1CC1=CC=CC=C1 WGNUAIUETGJVLG-UHFFFAOYSA-N 0.000 description 1
- HLXVKKMTKKRHED-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)propoxy]-6-fluoro-3,4-dihydro-1h-quinolin-2-one Chemical compound FC1=CC=2CCC(=O)NC=2C=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 HLXVKKMTKKRHED-UHFFFAOYSA-N 0.000 description 1
- AAJGHZBSNSBJHU-UHFFFAOYSA-N 7-[3-(4-benzylpiperidin-1-yl)propoxy]-8-bromo-6-chloro-3,4-dihydro-1h-quinolin-2-one Chemical compound ClC1=CC=2CCC(=O)NC=2C(Br)=C1OCCCN(CC1)CCC1CC1=CC=CC=C1 AAJGHZBSNSBJHU-UHFFFAOYSA-N 0.000 description 1
- APJPVIGAPZFBAM-UHFFFAOYSA-N 7-[3-(4-phenyl-4-propanoylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1(C(=O)CC)C1=CC=CC=C1 APJPVIGAPZFBAM-UHFFFAOYSA-N 0.000 description 1
- OUWSDTRQZKYREJ-UHFFFAOYSA-N 7-[3-(4-phenylpiperidin-1-yl)propoxy]-1-(3-phenylpropyl)-3,4-dihydroquinolin-2-one Chemical compound C1=C2N(CCCC=3C=CC=CC=3)C(=O)CCC2=CC=C1OCCCN(CC1)CCC1C1=CC=CC=C1 OUWSDTRQZKYREJ-UHFFFAOYSA-N 0.000 description 1
- CSWOXKBZQHOCTF-UHFFFAOYSA-N 7-[3-[4-(3-chlorophenyl)-1-methylpiperidin-1-ium-1-yl]-2-hydroxypropoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CC(O)COC=2C=C3NC(=O)C=CC3=CC=2)CCC1C1=CC=CC(Cl)=C1 CSWOXKBZQHOCTF-UHFFFAOYSA-N 0.000 description 1
- IZLKEOYSQAJSOI-UHFFFAOYSA-N 7-[3-[4-(4-fluorophenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=C3NC(=O)C=CC3=CC=2)CCC1C1=CC=C(F)C=C1 IZLKEOYSQAJSOI-UHFFFAOYSA-N 0.000 description 1
- YUSRYUVUQZAREX-UHFFFAOYSA-N 7-[6-(4-benzylpiperidin-1-yl)hexoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2NC(=O)CCC2=CC=C1OCCCCCCN(CC1)CCC1CC1=CC=CC=C1 YUSRYUVUQZAREX-UHFFFAOYSA-N 0.000 description 1
- SGQNDTHKJSEPET-UHFFFAOYSA-N 7-[6-(4-hydroxy-4-phenylpiperidin-1-yl)hexoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCCCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1(O)C1=CC=CC=C1 SGQNDTHKJSEPET-UHFFFAOYSA-N 0.000 description 1
- LGSVELDCSDHDES-UHFFFAOYSA-N 7-hydroxy-4-phenyl-1h-quinolin-2-one Chemical compound C=1C(=O)NC2=CC(O)=CC=C2C=1C1=CC=CC=C1 LGSVELDCSDHDES-UHFFFAOYSA-N 0.000 description 1
- CCIMBZKQVFPGCF-UHFFFAOYSA-N 7-methoxy-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=CC(OC)=CC=C21 CCIMBZKQVFPGCF-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- FGDWUKJPFKFCDD-UHFFFAOYSA-N 8-[3-(4-acetyl-4-phenylpiperidin-1-yl)-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CC(O)COC=2C=3NC(=O)CCC=3C=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 FGDWUKJPFKFCDD-UHFFFAOYSA-N 0.000 description 1
- MIZMBLPNZSKKKY-UHFFFAOYSA-N 8-[3-(4-acetyl-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=3NC(=O)CCC=3C=CC=2)CCC1(C(=O)C)C1=CC=CC=C1 MIZMBLPNZSKKKY-UHFFFAOYSA-N 0.000 description 1
- JUFQUTFNINIBRY-UHFFFAOYSA-N 8-[3-(4-benzylpiperidin-1-yl)-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=CC=2CCC(=O)NC=2C=1OCC(O)CN(CC1)CCC1CC1=CC=CC=C1 JUFQUTFNINIBRY-UHFFFAOYSA-N 0.000 description 1
- ZBVIWJGSBIEQDH-UHFFFAOYSA-N 8-[3-(4-benzylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12NC(=O)CCC2=CC=CC=1OCCCN(CC1)CCC1CC1=CC=CC=C1 ZBVIWJGSBIEQDH-UHFFFAOYSA-N 0.000 description 1
- UBSGDGFQAPQNSR-UHFFFAOYSA-N 8-[3-(4-hexanoyl-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=3NC(=O)CCC=3C=CC=2)CCC1(C(=O)CCCCC)C1=CC=CC=C1 UBSGDGFQAPQNSR-UHFFFAOYSA-N 0.000 description 1
- AQXWZJWNTMUWFM-UHFFFAOYSA-N 8-[3-(4-hydroxy-4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CN(CCCOC=2C=3NC(=O)CCC=3C=CC=2)CCC1(O)C1=CC=CC=C1 AQXWZJWNTMUWFM-UHFFFAOYSA-N 0.000 description 1
- HTDYYIJTWVTQRY-UHFFFAOYSA-N 8-[3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12NC(=O)CCC2=CC=CC=1OCCCN(CC1)CCC1C1=CC=CC=C1 HTDYYIJTWVTQRY-UHFFFAOYSA-N 0.000 description 1
- NBCOLFWEQMBCPD-UHFFFAOYSA-N 8-bromo-5-(oxiran-2-ylmethoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=2CCC(=O)NC=2C(Br)=CC=C1OCC1CO1 NBCOLFWEQMBCPD-UHFFFAOYSA-N 0.000 description 1
- CUIKMKFHNHPLPY-UHFFFAOYSA-N 8-bromo-5-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C(Br)=CC=C2O CUIKMKFHNHPLPY-UHFFFAOYSA-N 0.000 description 1
- NPHKGWGKQYIFQK-UHFFFAOYSA-N 8-bromo-6-chloro-7-[2-hydroxy-3-(4-phenylpiperidin-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound ClC=1C=C2CCC(=O)NC2=C(Br)C=1OCC(O)CN(CC1)CCC1C1=CC=CC=C1 NPHKGWGKQYIFQK-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- FHDCULXRJMQHLF-UHFFFAOYSA-N Cl.ClC1=CC=C(C=C1)C1CCN(CC1)CCCOC=1C(NC2=CC=CC=C2C1)=O Chemical compound Cl.ClC1=CC=C(C=C1)C1CCN(CC1)CCCOC=1C(NC2=CC=CC=C2C1)=O FHDCULXRJMQHLF-UHFFFAOYSA-N 0.000 description 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 244000239659 Eucalyptus pulverulenta Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000396922 Pontia daplidice Species 0.000 description 1
- BERPCVULMUPOER-UHFFFAOYSA-N Quinolinediol Chemical class C1=CC=C2NC(=O)C(O)=CC2=C1 BERPCVULMUPOER-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- 239000003655 absorption accelerator Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 208000002205 allergic conjunctivitis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000024998 atopic conjunctivitis Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- VEIWYFRREFUNRC-UHFFFAOYSA-N hydron;piperidine;chloride Chemical compound [Cl-].C1CC[NH2+]CC1 VEIWYFRREFUNRC-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- QXUAFCKBYYPTPQ-ZWKAXHIPSA-L magnesium (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol octadecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O QXUAFCKBYYPTPQ-ZWKAXHIPSA-L 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- AQLYZDRHNHZHIS-UHFFFAOYSA-N quinoline-2,6-diol Chemical compound N1C(=O)C=CC2=CC(O)=CC=C21 AQLYZDRHNHZHIS-UHFFFAOYSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12045279A JPS5643280A (en) | 1979-09-18 | 1979-09-18 | Carbostyril derivative |
| JP12556579A JPS5649360A (en) | 1979-09-28 | 1979-09-28 | 2-oxoquinoline derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH645892A5 true CH645892A5 (de) | 1984-10-31 |
Family
ID=26458032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH694080A CH645892A5 (de) | 1979-09-18 | 1980-09-17 | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel. |
Country Status (19)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2901336A1 (de) | 1979-01-15 | 1980-07-24 | Boehringer Mannheim Gmbh | Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| CH655110A5 (de) * | 1982-09-03 | 1986-03-27 | Otsuka Pharma Co Ltd | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. |
| GB8426584D0 (en) * | 1984-10-19 | 1984-11-28 | Beecham Group Plc | Compounds |
| US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
| US4921862A (en) * | 1986-05-29 | 1990-05-01 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-amp phosphodiesterase inhibitors |
| US4792561A (en) * | 1986-05-29 | 1988-12-20 | Syntex (U.S.A.) Inc. | Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors |
| DK397387A (da) * | 1986-07-31 | 1988-02-01 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser |
| FR2620704B1 (fr) * | 1987-09-17 | 1991-04-26 | Sanofi Sa | Derives de (benzyl-4 piperidino)-1 propanol-2, leur preparation, leur utilisation comme antimicrobiens et les produits les contenant |
| US5227381A (en) * | 1988-05-02 | 1993-07-13 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative |
| US5082847A (en) * | 1990-07-18 | 1992-01-21 | Syntex (U.S.A.) Inc. | Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility |
| JP2686887B2 (ja) * | 1992-08-11 | 1997-12-08 | キッセイ薬品工業株式会社 | ピペリジノ−３，４−ジヒドロカルボスチリル誘導体 |
| IT1264816B1 (it) * | 1993-07-28 | 1996-10-10 | Pergam Srl | Procedimento per la preparazione di derivati del procedimento per la preparazione di derivati del 3,4-diidrocarbostirile 3,4-diidrocarbostirile |
| ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| US7229986B2 (en) | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
| ES2250919T5 (es) † | 2003-01-09 | 2010-12-03 | Otsuka Pharmaceutical Co., Ltd. | Procedimiento de preparación de aripiprazol. |
| DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| US8541404B2 (en) | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3629266A (en) * | 1969-03-03 | 1971-12-21 | Miles Lab | (phenyl piperidino alkyl)3 4-dihydrocarbostyrils |
| JPS517672B2 (enrdf_load_stackoverflow) * | 1972-04-13 | 1976-03-10 | ||
| US3910924A (en) * | 1972-04-13 | 1975-10-07 | Otsuka Pharma Co Ltd | 3,4-Dihydrocarbostyril derivatives and a process for preparing the same |
| US4256890A (en) * | 1972-09-14 | 1981-03-17 | Otsukapharmaceutical Co., Ltd. | 3,4-Dihydrocarbostyril derivatives and process for producing the same |
| JPS5239035B2 (enrdf_load_stackoverflow) * | 1972-12-14 | 1977-10-03 | ||
| JPS5310986B2 (enrdf_load_stackoverflow) * | 1974-02-05 | 1978-04-18 | ||
| JPS5310989B2 (enrdf_load_stackoverflow) * | 1974-04-25 | 1978-04-18 | ||
| US3994900A (en) * | 1976-01-23 | 1976-11-30 | E. R. Squibb & Sons, Inc. | 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones |
| JPS609501B2 (ja) * | 1976-05-07 | 1985-03-11 | 大塚製薬株式会社 | 新規３，４−ジヒドロカルボスチリル誘導体 |
| JPS5919541B2 (ja) * | 1976-03-17 | 1984-05-07 | 大塚製薬株式会社 | 新規３，４−ジヒドロカルボスチリル誘導体 |
| US4210753A (en) * | 1976-03-17 | 1980-07-01 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compounds |
| CH619453A5 (enrdf_load_stackoverflow) * | 1976-03-17 | 1980-09-30 | Otsuka Pharma Co Ltd | |
| GB1574665A (en) * | 1976-05-08 | 1980-09-10 | Otsuka Pharma Co Ltd | 3,4-dihydrocarbostyril derivatives and process for preparing the same |
| JPS6019295B2 (ja) * | 1977-03-04 | 1985-05-15 | 大塚製薬株式会社 | カルボスチリル誘導体及びその製造法 |
| JPS5416478A (en) * | 1977-07-08 | 1979-02-07 | Otsuka Pharmaceut Co Ltd | 3,4-dihydrocarbostyril herivative |
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| DE2827566A1 (de) * | 1978-06-23 | 1980-01-10 | Boehringer Mannheim Gmbh | 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung |
| JPS5589221A (en) * | 1978-12-28 | 1980-07-05 | Otsuka Pharmaceut Co Ltd | Antihistaminic agent |
| JPS5589222A (en) * | 1978-12-28 | 1980-07-05 | Otsuka Pharmaceut Co Ltd | Antihistaminic agent |
| DE2901336A1 (de) * | 1979-01-15 | 1980-07-24 | Boehringer Mannheim Gmbh | Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
-
1980
- 1980-09-11 DE DE19803034237 patent/DE3034237A1/de active Granted
- 1980-09-12 AU AU62381/80A patent/AU518144B2/en not_active Ceased
- 1980-09-12 FR FR8019708A patent/FR2465732A1/fr active Granted
- 1980-09-16 FI FI802905A patent/FI76322C/fi not_active IP Right Cessation
- 1980-09-16 SU SU802982853A patent/SU1091857A3/ru active
- 1980-09-17 NL NLAANVRAGE8005188,A patent/NL187912C/xx not_active IP Right Cessation
- 1980-09-17 PT PT71810A patent/PT71810B/pt unknown
- 1980-09-17 AT AT0465780A patent/AT376972B/de not_active IP Right Cessation
- 1980-09-17 CH CH694080A patent/CH645892A5/de not_active IP Right Cessation
- 1980-09-17 DK DK394080A patent/DK158984C/da active
- 1980-09-17 CA CA000360402A patent/CA1151172A/en not_active Expired
- 1980-09-17 NO NO802762A patent/NO154841C/no unknown
- 1980-09-17 SE SE8006498A patent/SE439632B/sv not_active IP Right Cessation
- 1980-09-17 AR AR282565A patent/AR230280A1/es active
- 1980-09-18 GB GB8030207A patent/GB2063869B/en not_active Expired
- 1980-09-18 ES ES495163A patent/ES495163A0/es active Granted
- 1980-09-18 MX MX809034U patent/MX6806E/es unknown
- 1980-09-18 IT IT68445/80A patent/IT1129263B/it active
-
1982
- 1982-03-12 US US06/357,769 patent/US4482560A/en not_active Expired - Fee Related
- 1982-05-18 AR AR289431A patent/AR230059A1/es active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3152880C2 (enrdf_load_stackoverflow) | ||
| CH645892A5 (de) | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel. | |
| DE69113148T2 (de) | Thioxo-Heterocyclen und ihre pharmazeutische Verwendung. | |
| DE69013836T2 (de) | Benzimidazolverbindungen und deren Anwendung. | |
| EP0569802B1 (de) | Arylacetamide | |
| DE69306094T2 (de) | Naphthalin-Derivate | |
| DE69118388T2 (de) | Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung | |
| DE3784401T2 (de) | Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung. | |
| CH641455A5 (de) | Carbostyril-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| DE3433327A1 (de) | 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)alkyl)piperazinderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel | |
| EP0013894B1 (de) | Neue Arylether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| DE3875866T2 (de) | Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie. | |
| DE3617183A1 (de) | Substituierte benzylether | |
| EP0499926A1 (de) | 2-Substituierte Chinoline, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
| DE69206725T2 (de) | Benzolsulfonamidderivate als 5-Lipoxygenasehemmer | |
| EP0414076B1 (de) | Cyclisch substituierte (Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate | |
| DE3633977A1 (de) | Tetrahydrochinolinderivate, ein verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen | |
| CH636099A5 (de) | Verfahren zur herstellung von piperidinopropanolderivaten. | |
| EP0007399B1 (de) | Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung | |
| DE69329084T2 (de) | Benzoxazepin-Derivate als Cholinesterase-Inhibitoren | |
| DE69209099T2 (de) | Sulfonamidderivate | |
| WO1998034920A1 (de) | 2-amino-substituierte pyridine verwendbar zur behandlung von arteriosklerose und hyperlipoproteinemie | |
| DE2737630C2 (enrdf_load_stackoverflow) | ||
| EP0164633A2 (de) | Indolderivate | |
| DE2852088A1 (de) | Substituierte pyrrolidine, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |